Foster currently heads translational development of Rgenix’s pipeline and leads the implementation of the biomarker
and diagnostic strategy. He is also a key member of the corporate strategy team where he supports
product and portfolio planning.
Before coming to Rgenix, Foster was a Management
Consultant with the Life Sciences Practice of Navigant Consulting/Easton Associates
where he served clients in the pharmaceutical, biotech, private equity and medical devices sectors.
As a consultant, Foster helped his clients address key issues in generating market forecasts and
product valuation, portfolio optimization and life cycle management for both early stage and
marketed products. Foster was previously a Postdoctoral Fellow at the NYU Cancer Institute where
he was awarded the Kimmel Foundation Fellowship to study and develop novel modulators of the
Foster received his Ph.D. in Molecular and Cell Biology from the University of
California at Berkeley, an M.P.H in Health Policy and Management from Columbia University Mailman
School of Public Health and a B.Sc. with Honors in Microbiology and Biochemistry
from St. Xavier’s College, Mumbai, India.Top